Ventas Stock Forecast for 2023 - 2025 - 2030
Updated on 04/25/2024
Ventas Stock Forecast and Price Target
Ventas's most recent price target of $50.00 for 2024 was provided by renowned analysts over the past few months, with an average prediction of $50.00. If this prediction is correct, Ventas's stock could rise by 15.31 percent from its current trading price. The potential increase for the stock is $50.00 per share, with a possible range of $46.00 to $70.00. Even if you are not interested in VTR stock, you should be aware of its competitors and their current standings.
15.31% Upside
Ventas Fair Value Forecast for 2023 - 2025 - 2030
Ventas's Price has decreased by 100.00% In the last three years, from $8.96 to $0.00. In the next year, analysts believe that Fair Value will reach $46.66 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| WELL Stock Forecast | HAN-GINS Indxx Healthcare Inno... | Outperform |
17
|
$94.00 | Buy/Sell | $97.00 | 10.64% |
| O Stock Forecast | Realty Income | Outperform |
14
|
$53.80 | Buy/Sell | $63.45 | 11.52% |
| AVB Stock Forecast | AvalonBay Communities | Outperform |
16
|
$191.32 | Buy/Sell | $197.24 | 3.49% |
| EQR Stock Forecast | Equity Residential | Outperform |
15
|
$64.88 | Buy/Sell | $66.48 | 2.50% |
| ARE Stock Forecast | Alexandria Real Estate Equitie... | Buy |
15
|
$117.30 | Buy/Sell | $142.08 | 19.35% |
Ventas Revenue Forecast for 2023 - 2025 - 2030
In the last three years, Ventas's Revenue has grown, rising from $3.80B to $4.50B – a growth of 18.41%. In the next year, analysts believe that Revenue will reach $4.67B – an increase of 3.78%. For the next seven years, the forecast is for Revenue to grow by 17.18%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| ESS Stock Forecast | Essex Property Trust | Hold |
17
|
$247.21 | Buy/Sell | $246.82 | -1.30% |
| PEAK Stock Forecast | Healthpeak Properties | Outperform |
14
|
$18.34 | Buy/Sell | $22.83 | 14.50% |
| HST Stock Forecast | Host Hotels & Resorts | Outperform |
14
|
$18.89 | Buy/Sell | $22.21 | 21.76% |
.jpg)
Ventas Dividend per Share Forecast for 2023 - 2025 - 2030
In the last three years, Ventas's Dividend per Share has decreased from $2.14 to $1.80 – a 15.89% drop! In the next year, analysts believe that Dividend per Share will reach $2.11 – an increase of 17.22%. For the next seven years, experts predict that Ventas's Dividend per Share will grow at a rate of 91.67%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| KIM Stock Forecast | Kimco Realty | Outperform |
12
|
$18.42 | Buy/Sell | $23.58 | 22.15% |
| REG Stock Forecast | Regency Centers | Outperform |
15
|
$59.06 | Buy/Sell | $71.39 | 18.52% |
| BXP Stock Forecast | Boston Properties | Outperform |
15
|
$61.95 | Buy/Sell | $72.84 | 17.84% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| OHI Stock Forecast | Omega Healthcare Investors | Outperform |
16
|
$30.90 | Buy/Sell | $32.43 | 6.80% |
| HR Stock Forecast | Healthcare Realty Trust | Hold |
18
|
$14.03 | Buy/Sell | $18.00 | 14.04% |
| VNO Stock Forecast | Vornado Realty Trust | Underperform |
10
|
$26.40 | Buy/Sell | $25.69 | -1.52% |
Ventas EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Ventas's EBITDA has grown by 15.72%, rising from $1.53B to $1.77B. For the next year, analysts predict that EBITDA will reach $1.94B – an increase of 9.62%. Over the next seven years, experts believe that Ventas's EBITDA will grow at a rate of 77.78%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SBRA Stock Forecast | Sabra Health Care REIT | Outperform |
12
|
$13.65 | Buy/Sell | $14.92 | 17.22% |
| CTRE Stock Forecast | CareTrust REIT | Outperform |
16
|
$23.95 | Buy/Sell | $24.75 | 4.38% |
| DOC Stock Forecast | Physicians Realty Trust | - |
14
|
$11.23 | Buy/Sell | $14.78 | -84.33% |
Ventas EBIT Forecast for 2023 - 2025 - 2030
In the last three years, Ventas's EBIT has grown, moving from $596.38M to $644.33M – an increase of 8.04%. According to 3 prominent analysts, Ventas's EBIT will fall by 13.33% in the next year, reaching $558.44M. Looking ahead to seven years, experts forecast that EBIT will grow by 120.29%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| BKD Stock Forecast | Brookdale Senior Living | Outperform |
10
|
$6.86 | Buy/Sell | $6.48 | 16.62% |
| CHCT Stock Forecast | Community Healthcare Trust | Outperform |
16
|
$25.65 | Buy/Sell | $35.50 | 24.76% |
| UHT Stock Forecast | Universal Health Realty Income... | - |
16
|
$41.40 | Buy/Sell | $33.00 | -100.00% |
Ventas EPS Price Prediction Forecast for 2023 - 2025 - 2030
Ventas's EPS has decreased by 100.00% In the last three years, from $0.58 to $0.00. In the next year, analysts believe that EPS will reach $0.33 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.
.jpg)